Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2011-03-11

FDA Approved: PROPECIA — Supplemental Application (Organon LLC)

View source ↗

Summary

The FDA approved a supplemental labeling change for Propecia (finasteride) submitted by Organon LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Propecia (finasteride)

Snippet

SUPPL AP for PROPECIA (FINASTERIDE)